Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 2157-2167

  Ono, Chikako ^a   Ninomiya, Akinori ^a   Yamamoto, Satomi ^a   Abe, Takayuki ^a,c   Wen, Xiauyu ^a,d   Fukuhara, Takasuke ^a   Sasai, Miwa ^a   Yamamoto, Masahiro ^a   Saitoh, Tatsuya ^b   Satoh, Takashi ^b   Kawai, Taro ^b,e   Ishii, Ken J ^b   Akira, Shizuo ^b   Okamoto, Toru ^a   Matsuura, Yoshiharu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^e NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; DNA PRIMERS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MOTHS; NUCLEOPOLYHEDROVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84893462043     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03055-13     Document Type: Article

References (82)

1. Luckow VA, Summers MD. 1988. Signals important for high-level expression of foreign genes in Autographa californica nuclear polyhedrosis virus expression vectors. Virology 167:56-71. http://dx.doi.org/10.1016/0042-6822(88)90054-2.
2. Matsuura Y, Possee RD, Overton HA, Bishop DH. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250. http://dx.doi.org/10.1099/0022-1317-68-5-1233.
3. Tani H, Nishijima M, Ushijima H, Miyamura T, Matsuura Y. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279:343-353. http://dx.doi.org/10.1006/viro.2000.0699.
4. Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y, Okahashi N, Kitagawa Y, Watanabe R, Mochizuki R, Moriishi K, Matsuura Y. 2003. In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 77:9799-9808. http://dx.doi.org/10.1128/JVI.77.18.9799-9808.2003.
5. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 92:10099-10103. http://dx.doi.org/10.1073/pnas.92.22.10099.
6. Boyce FM, Bucher NL. 1996. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 93:2348-2352. http://dx.doi.org/10.1073/pnas.93.6.2348.
7. Shoji I, Aizaki H, Tani H, Ishii K, Chiba T, Saito I, Miyamura T, Matsuura Y. 1997. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78: 2657-2664.
8. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H. 2003. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 171:1133-1139. http://www.jimmunol.org/content/171/3/1133.long.
9. Beck NB, Sidhu JS, Omiecinski CJ. 2000. Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes. Gene Ther. 7:1274-1283. http://dx.doi.org/10.1038/sj.gt.3301246.
10. Gronowski AM, Hilbert DM, Sheehan KC, Garotta G, Schreiber RD. 1999. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 73:9944-9951.
11. Hofmann C, Strauss M. 1998. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5:531-536. http://dx.doi.org/10.1038/sj.gt.3300607.
12. Sandig V, Hofmann C, Steinert S, Jennings G, Schlag P, Strauss M. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7:1937-1945. http://dx.doi.org/10.1089/hum.1996.7.16-1937.
13. Airenne KJ, Hiltunen MO, Turunen MP, Turunen AM, Laitinen OH, Kulomaa MS, Yla-Herttuala S. 2000. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther. 7:1499-1504. http://dx.doi.org/10.1038/sj.gt.3301269.
14. Pieroni L, Maione D, La Monica N. 2001. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene Ther. 12: 871-881. http://dx.doi.org/10.1089/104303401750195845.
15. Lehtolainen P, Tyynela K, Kannasto J, Airenne KJ, Yla-Herttuala S. 2002. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus-and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther. 9:1693-1699. http://dx.doi.org/10.1038/sj.gt.3301854.
16. Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, Mallet J. 2000. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc. Natl. Acad. Sci. U.S.A. 97:14638-14643. http://dx.doi.org/10.1073/pnas.260472897.
17. Haeseleer F, Imanishi Y, Saperstein DA, Palczewski K. 2001. Gene transfer mediated by recombinant baculovirus into mouse eye. Invest. Ophthalmol. Vis. Sci. 42:3294-3300. http://www.iovs.org/content/42/13/3294.long.
18. Abe T, Hemmi H, Miyamoto H, Moriishi K, Tamura S, Takaku H, Akira S, Matsuura Y. 2005. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol. 79:2847-2858. http://dx.doi.org/10.1128/JVI.79.5.2847-2858.2005.
19. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, Uematsu S, Takeuchi O, Ishii KJ, Kawai T, Akira S, Matsuura Y. 2009. Baculovirus induces type I interferon production through Toll-like receptor-dependent and-independent pathways in a cell-type-specific manner. J. Virol. 83:7629-7640. http://dx.doi.org/10.1128/JVI.00679-09.
20. Boulaire J, Zhao Y, Wang S. 2009. Gene expression profiling to define host response to baculoviral transduction in the brain. J. Neurochem. 109:1203-1214. http://dx.doi.org/10.1111/j.1471-4159.2009.06015.x.
21. Chen GY, Shiah HC, Su HJ, Chen CY, Chuang YJ, Lo WH, Huang JL, Chuang CK, Hwang SM, Hu YC. 2009. Baculovirus transduction of mesenchymal stem cells triggers the Toll-like receptor 3 pathway. J. Virol. 83:10548-10556. http://dx.doi.org/10.1128/JVI.01250-09.
22. Han Y, Niu M, An L, Li W. 2009. Upregulation of proinflammatory cytokines and NO production in BV-activated avian macrophage-like cell line (HD11) requires MAPK and NF-kappaB pathways. Int. Immunopharmacol. 9:817-823. http://dx.doi.org/10.1016/j.intimp.2009.03.008.
23. Wilson S, Baird M, Ward VK. 2008. Delivery of vaccine peptides by rapid conjugation to baculovirus particles. Vaccine 26:2451-2456. http://dx.doi.org/10.1016/j.vaccine.2008.03.027.
24. Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C. 2007. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 178:2361-2369. http://www.jimmunol.org/content/178/4/2361.long.
25. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137. http://dx.doi.org/10.1038/ni1303.
26. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658. http://dx.doi.org/10.1038/nri1900.
27. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40-48. http://dx.doi.org/10.1038/ni1282.
28. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103. http://dx.doi.org/10.1016/j.immuni.2005.12.003.
29. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. 2007. DAI (DLM-1/ZBP1) is a cytosolicDNAsensor and an activator of innate immune response. Nature 448:501-505. http://dx.doi.org/10.1038/nature06013.
30. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. http://dx.doi.org/10.1038/nature07317.
31. Jin L, Waterman PM, Jonscher KR, Short CM, Reisdorph NA, Cambier JC. 2008. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28:5014-5026. http://dx.doi.org/10.1128/MCB.00640-08.
32. Sun W, Li Y, Chen L, Chen H, You F, Zhou X, Zhou Y, Zhai Z, Chen D, Jiang Z. 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. U.S.A. 106:8653-8658. http://dx.doi.org/10.1073/pnas.0900850106.
33. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550. http://dx.doi.org/10.1016/j.immuni.2008.09.003.
34. Matsui K, Kumagai Y, Kato H, Sato S, Kawagoe T, Uematsu S, Takeuchi O, Akira S. 2006. Cutting edge: role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177:5785-5789. http://www.jimmunol.org/content/177/9/5785.long.
35. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-729. http://dx.doi.org/10.1038/nature06537.
36. Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, Miyamura T, Yoshimori T, Moriishi K, Matsuura Y. 2008. A singleamino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J. Virol. 82:3480-3489. http://dx.doi.org/10.1128/JVI.02253-07.
37. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113. http://dx.doi.org/10.1126/science.285.5424.110.
38. Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y. 2007. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81:8601-8612. http://dx.doi.org/10.1128/JVI.00608-07.
39. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199. http://dx.doi.org/10.1016/0378-1119(91)90434-D.
40. Mizushima S, Nagata S. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322. http://dx.doi.org/10.1093/nar/18.17.5322.
41. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796. http://dx.doi.org/10.1038/nm1268.
42. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066. http://dx.doi.org/10.1038/sj.gt.3301206.
43. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A. 2000. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am. J. Pathol. 157:449-461. http://dx.doi.org/10.1016/S0002-9440(10)64557-9.
44. Kataoka C, Kaname Y, Taguwa S, Abe T, Fukuhara T, Tani H, Moriishi K, Matsuura Y. 2012. Baculovirus GP64-mediated entry into mammalian cells. J. Virol. 86:2610-2620. http://dx.doi.org/10.1128/JVI.06704-11.
45. Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, Ahn J, Gutman D, Barber GN. 2013. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 50:5-15. http://dx.doi.org/10.1016/j.molcel.2013.01.039.
46. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S. 2009. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 106:20842-20846. http://dx.doi.org/10.1073/pnas.0911267106.
47. Choi MK, Wang Z, Ban T, Yanai H, Lu Y, Koshiba R, Nakaima Y, Hangai S, Savitsky D, Nakasato M, Negishi H, Takeuchi O, Honda K, Akira S, Tamura T, Taniguchi T. 2009. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc. Natl. Acad. Sci. U.S.A. 106:17870-17875. http://dx.doi.org/10.1073/pnas.0909545106.
48. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203: 1795-1803. http://dx.doi.org/10.1084/jem.20060792.
49. Lemon SM. 2010. Induction and evasion of innate antiviral responses by hepatitis C virus. J. Biol. Chem. 285:22741-22747. http://dx.doi.org/10.1074/jbc.R109.099556.
50. Correia-de-Sa P, Timoteo MA, Ribeiro JA. 2001. Synergism between A(2A)-adenosine receptor activation and vasoactive intestinal peptide to facilitate [3H]-acetylcholine release from the rat motor nerve terminals. Neurosci. Lett. 309:101-104. http://dx.doi.org/10.1016/S0304-3940(01)02030-4.
51. Nayak S, Herzog RW. 2010. Progress and prospects: immune responses to viral vectors. Gene Ther. 17:295-304. http://dx.doi.org/10.1038/gt.2009.148.
52. Olschowka JA, Bowers WJ, Hurley SD, Mastrangelo MA, Federoff HJ. 2003. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7:218-227. http://dx.doi.org/10.1016/S1525-0016(02)00036-9.
53. Sung RS, Qin L, Bromberg JS. 2001. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol. Ther. 3:757-767. http://dx.doi.org/10.1006/mthe.2001.0318.
54. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37-44. http://dx.doi.org/10.1089/hum.1997.8.1-37.
55. Volkman LE, Goldsmith PA. 1983. In vitro survey of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl. Environ. Microbiol. 45:1085-1093.
56. Carbonell LF, Klowden MJ, Miller LK. 1985. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J. Virol. 56:153-160.
57. Chen CY, Lin CY, Chen GY, Hu YC. 2011. Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol. Adv. 29:618-631. http://dx.doi.org/10.1016/j.biotechadv.2011.04.004.
58. Yoshida S, Araki H, Yokomine T. 2010. Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice. Infect. Immun. 78:595-602. http://dx.doi.org/10.1128/IAI.00877-09.
59. Yoshida S, Kondoh D, Arai E, Matsuoka H, Seki C, Tanaka T, Okada M, Ishii A. 2003. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 316:161-170. http://dx.doi.org/10.1016/j.virol.2003.08.003.
60. Strauss R, Huser A, Ni S, Tuve S, Kiviat N, Sow PS, Hofmann C, Lieber A. 2007. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol. Ther. 15:193-202. http://dx.doi.org/10.1038/sj.mt.6300008.
61. Fang R, Feng H, Nie H, Wang L, Tu P, Song Q, Zhou Y, Zhao J. 2010. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 28: 1803-1807. http://dx.doi.org/10.1016/j.vaccine.2009.12.005.
62. Rahman MM, Shaila MS, Gopinathan KP. 2003. Baculovirus display of fusion protein of Peste des petits ruminants virus and hemagglutination protein of Rinderpest virus and immunogenicity of the displayed proteins in mouse model. Virology 317:36-49. http://dx.doi.org/10.1016/j.virol.2003.08.022.
63. Tami C, Peralta A, Barbieri R, Berinstein A, Carrillo E, Taboga O. 2004. Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces. Vaccine 23:840-845. http://dx.doi.org/10.1016/j.vaccine.2004.03.070.
64. Grabowska AK, Lipinska AD, Rohde J, Szewczyk B, Bienkowska-Szewczyk K, Rziha HJ. 2009. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 27:3584-3591. http://dx.doi.org/10.1016/j.vaccine.2009.03.067.
65. Yang DG, Chung YC, Lai YK, Lai CW, Liu HJ, Hu YC. 2007. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol. Ther. 15:989-996. http://dx.doi.org/10.1038/mt.sj.6300131.
66. Kitagawa Y, Tani H, Limn CK, Matsunaga TM, Moriishi K, Matsuura Y. 2005. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J. Virol. 79:3639-3652. http://dx.doi.org/10.1128/JVI.79.6.3639-3652.2005.
67. Lung O, Westenberg M, Vlak JM, Zuidema D, Blissard GW. 2002. Pseudotyping Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64. J. Virol. 76:5729-5736. http://dx.doi.org/10.1128/JVI.76.11.5729-5736.2002.
68. Mangor JT, Monsma SA, Johnson MC, Blissard GW. 2001. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein. J. Virol. 75:2544-2556. http://dx.doi.org/10.1128/JVI.75.6.2544-2556.2001.
69. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. 2011. The helicase DDX41 senses intracellularDNAmediated by the adaptor STING in dendritic cells. Nat. Immunol. 12:959-965. http://dx.doi.org/10.1038/ni.2091.
70. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791. http://dx.doi.org/10.1126/science.1232458.
71. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-830. http://dx.doi.org/10.1126/science.1229963.
72. Dong X, Feng P. 2011. Murine gamma herpesvirus 68 hijacks MAVS and IKKbeta to abrogate NFkappaB activation and antiviral cytokine production. PLoS Pathog. 7:e1002336. http://dx.doi.org/10.1371/journal.ppat.1002336.
73. Sano M, Kato Y, Taira K. 2006. Sequence-specific interference by small RNAs derived from adenovirus VAI RNA. FEBS Lett. 580:1553-1564. http://dx.doi.org/10.1016/j.febslet.2006.01.085.
74. Chiu YH, Macmillan JB, Chen ZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-591. http://dx.doi.org/10.1016/j.cell.2009.06.015.
75. Yamaguchi T, Kawabata K, Kouyama E, Ishii KJ, Katayama K, Suzuki T, Kurachi S, Sakurai F, Akira S, Mizuguchi H. 2010. Induction of type I interferon by adenovirus-encoded small RNAs. Proc. Natl. Acad. Sci. U.S.A. 107:17286-17291. http://dx.doi.org/10.1073/pnas.1009823107.
76. Kenoutis C, Efrose RC, Swevers L, Lavdas AA, Gaitanou M, Matsas R, Iatrou K. 2006. Baculovirus-mediated gene delivery into mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J. Virol. 80:4135-4146. http://dx.doi.org/10.1128/JVI.80.8.4135-4146.2006.
77. Fujita R, Matsuyama T, Yamagishi J, Sahara K, Asano S, Bando H. 2006. Expression of Autographa californica multiple nucleopolyhedrovirus genes in mammalian cells and upregulation of the host beta-actin gene. J. Virol. 80: 2390-2395. http://dx.doi.org/10.1128/JVI.80.5.2390-2395.2006.
78. Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-Kitazume A, Kiyohashi K, Murakawa M, Nishimura-Sakurai Y, Azuma S, Tasaka-Fujita M, Asahina Y, Yoneyama M, Fujita T, Watanabe M. 2013. Hepatitis C virus NS4B protein targets STING and abrogates RIGI-mediated type I interferon-dependent innate immunity. Hepatology 57: 46-58. http://dx.doi.org/10.1002/hep.26017.
79. Ding Q, Cao X, Lu J, Huang B, Liu YJ, Kato N, Shu HB, Zhong J. 2013. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatol. 59:52-58. http://dx.doi.org/10.1016/j.jhep.2013.03.019.
80. Maasoumy B, Wedemeyer H. 2012. Natural history of acute and chronic hepatitis C. Best Pract. Res. Clin. Gastroenterol. 26:401-412. http://dx.doi.org/10.1016/j.bpg.2012.09.009.
81. Sarrazin C, Zeuzem S. 2010. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138:447-462. http://dx.doi.org/10.1053/j.gastro.2009.11.055.
82. Chen GY, Hwang SM, Su HJ, Kuo CY, Luo WY, Lo KW, Huang CC, Chen CL, Yu SH, Hu YC. 2012. Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J. Virol. 86: 8041-8049. http://dx.doi.org/10.1128/JVI.00808-12.